Log In
Print
BCIQ
Print
Print this Print this
 

Rifaximin soluble solid dispersion (SSD)

  Manage Alerts
Collapse Summary General Information
Company Salix Pharmaceuticals Inc.
DescriptionNext-generation rifaximin, a non-absorbed broad spectrum antibiotic
Molecular Target Bacterial RNA polymerase
Mechanism of ActionRNA polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationCirrhosis
Indication DetailsPrevent the complications of early decompensated liver cirrhosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today